Peritumoral-to-tumoral apparent diffusion coefficient ratio as a marker of tumor microenvironment activity across breast cancer molecular subtypes
5 affiliations
- 1Ankara Bilkent City Hospital, Clinic of Radiology, Ankara, Türkiye
- 2Ankara Medipol University Faculty of Medicine, Department of Radiology, Ankara, Türkiye
- 3Ankara Bilkent City Hospital, Yıldırım Beyazıt University, Department of Radiology, Ankara, Türkiye
- 4İstanbul Medeniyet University Faculty of Medicine, Department of Radiology, İstanbul, Türkiye
- 5Yüksek İhtisas University Faculty of Medicine, Department of Surgery, Ankara, Türkiye
Abstract
PURPOSE: This study aimed to evaluate the prognostic significance of tumoral apparent diffusion coefficient (tADC), peritumoral ADC (pADC), and the peritumoral-to-tumoral ADC (p/tADC) ratio in invasive breast cancers using high-resolution diffusion-weighted imaging.
METHODS: A retrospective cohort of 149 patients with invasive breast cancer was analyzed. pADC, tADC, and p/tADC values were independently measured by two experienced radiologists. The associations between these parameters and histological grade, receptor status, Ki-67 index, and molecular subtypes were assessed. Interobserver agreement was evaluated using the intraclass correlation coefficient (ICC), and multivariate logistic regression was performed to identify independent predictors.
RESULTS: Although tADC was significantly associated only with tumor size (P < 0.050), both pADC and p/tADC were significantly associated with high histological grade, estrogen receptor/progesterone receptor negativity, human epidermal growth factor receptor 2 positivity, and high Ki-67 index(P < 0.01). The p/tADC ratio emerged as an independent predictor of high-grade tumors and Ki-67 ≥ 20%. Excellent interobserver agreement was observed for all ADC measurements (ICC > 0.90).
CONCLUSION: The p/tADC ratio reflects stromal and microenvironmental alterations associated with tumor aggressiveness and demonstrates stronger prognostic relevance than tADC alone. Incorporating the p/tADC ratio into routine magnetic resonance imaging (MRI) interpretation may improve preoperative risk stratification and support personalized treatment planning in invasive breast cancer.
CLINICAL SIGNIFICANCE: The p/tADC ratio reflects stromal and microenvironmental changes associated with tumor aggressiveness and may serve as a non-invasive imaging biomarker. Its integration into preoperative MRI protocols may facilitate risk stratification and personalized treatment planning.
Related
- Apparent diffusion coefficient values on MRI as biomarkers for pre operative prediction of prognostic factors in endometrial cancer
- Combined apparent diffusion coefficient histogram and MRI-based fractal analysis for predicting lymph node metastasis in esophageal squamous cell carcinoma
- Diagnostic value of a multiparametric magnetic resonance imaging-based nomogram incorporating apparent diffusion coefficient in preoperative differentiation of phyllodes tumors from breast cancer: a retrospective study
- Apparent diffusion coefficient histogram parameters of the whole tumor based on whole-body magnetic resonance imaging can better characterize the tumor burden of multiple myeloma and predict survival prognosis
- Associations Between Apparent Diffusion Coefficient Values of Breast Tumors Presenting as Non-Mass Enhancement and Ki-67 Index
BibTeX
@article{gundogdu2026peritumoraltotumoral,
title = {{Peritumoral-to-tumoral apparent diffusion coefficient ratio as a marker of tumor microenvironment activity across breast cancer molecular subtypes}},
author = {Seçil Gündoğdu and Eda Elverici and Arzu Özsoy and Leman Günbey Karabekmez and Muhammed Said Beşler and Emre Gündoğdu},
journal = {Diagnostic and Interventional Radiology},
year = {2026},
month = nov,
doi = {10.4274/dir.2026.263742},
url = {https://doi.org/10.4274/dir.2026.263742},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Peritumoral-to-tumoral apparent diffusion coefficient ratio as a marker of tumor microenvironment activity across breast cancer molecular subtypes
AU - Seçil Gündoğdu
AU - Eda Elverici
AU - Arzu Özsoy
AU - Leman Günbey Karabekmez
AU - Muhammed Said Beşler
AU - Emre Gündoğdu
PY - 2026
DA - 2026/11/02
JO - Diagnostic and Interventional Radiology
DO - 10.4274/dir.2026.263742
UR - https://doi.org/10.4274/dir.2026.263742
AB - PURPOSE: This study aimed to evaluate the prognostic significance of tumoral apparent diffusion coefficient (tADC), peritumoral ADC (pADC), and the peritumoral-to-tumoral ADC (p/tADC) ratio in invasive breast cancers using high-resolution diffusion-weighted imaging. METHODS: A retrospective cohort of 149 patients with invasive breast cancer was analyzed. pADC, tADC, and p/tADC values were independently measured by two experienced radiologists. The associations between these parameters and histological grade, receptor status, Ki-67 index, and molecular subtypes were assessed. Interobserver agreement was evaluated using the intraclass correlation coefficient (ICC), and multivariate logistic regression was performed to identify independent predictors. RESULTS: Although tADC was significantly associated only with tumor size (P < 0.050), both pADC and p/tADC were significantly associated with high histological grade, estrogen receptor/progesterone receptor negativity, human epidermal growth factor receptor 2 positivity, and high Ki-67 index(P < 0.01). The p/tADC ratio emerged as an independent predictor of high-grade tumors and Ki-67 ≥ 20%. Excellent interobserver agreement was observed for all ADC measurements (ICC > 0.90). CONCLUSION: The p/tADC ratio reflects stromal and microenvironmental alterations associated with tumor aggressiveness and demonstrates stronger prognostic relevance than tADC alone. Incorporating the p/tADC ratio into routine magnetic resonance imaging (MRI) interpretation may improve preoperative risk stratification and support personalized treatment planning in invasive breast cancer. CLINICAL SIGNIFICANCE: The p/tADC ratio reflects stromal and microenvironmental changes associated with tumor aggressiveness and may serve as a non-invasive imaging biomarker. Its integration into preoperative MRI protocols may facilitate risk stratification and personalized treatment planning.
SN - 1305-3825
SN - 1305-3612
ER -